| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Soligenix Inc (NASDAQ: SNGX)
SNGX Technical Analysis
4
| As on 1st Aug 2025 SNGX STOCK Price closed @ 2.74 and we RECOMMEND Buy for LONG-TERM with Stoploss of 2.62 & Strong Buy for SHORT-TERM with Stoploss of 0.61 we also expect STOCK to react on Following IMPORTANT LEVELS. |
SNGXSTOCK Price
| Open | 2.66 | Change | Price | % |
| High | 2.91 | 1 Day | -0.19 | -6.48 |
| Low | 2.39 | 1 Week | 1.32 | 92.96 |
| Close | 2.74 | 1 Month | 0.96 | 53.93 |
| Volume | 7783339 | 1 Year | 2.06 | 302.94 |
| 52 Week High 7.73 | 52 Week Low 0.31 | ||||
NASDAQ USA Most Active Stocks
| AMRS | 0.14 | 100.00% |
| NVDA | 173.72 | -2.33% |
| OPEN | 2.10 | 14.13% |
| EQ | 0.71 | 82.05% |
| AMZN | 214.75 | -8.27% |
| NCNA | 0.04 | 0.00% |
| LMDX | 0.02 | 0.00% |
| BTAI | 1.37 | 4.58% |
| AKTS | 0.04 | 0.00% |
| AAPL | 202.38 | -2.50% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| SNGX Daily Charts |
SNGX Intraday Charts |
Whats New @ Bazaartrend |
SNGX Free Analysis |
|
|
SNGX Important Levels Intraday
| RESISTANCE | 3.74 |
| RESISTANCE | 3.42 |
| RESISTANCE | 3.22 |
| RESISTANCE | 3.02 |
| SUPPORT | 2.46 |
| SUPPORT | 2.26 |
| SUPPORT | 2.06 |
| SUPPORT | 1.74 |
SNGX Forecast August 2025
| 4th UP Forecast | 3.16 |
| 3rd UP Forecast | 3.03 |
| 2nd UP Forecast | 2.94 |
| 1st UP Forecast | 2.86 |
| 1st DOWN Forecast | 2.62 |
| 2nd DOWN Forecast | 2.54 |
| 3rd DOWN Forecast | 2.45 |
| 4th DOWN Forecast | 2.32 |
SNGX Weekly Forecast
| 4th UP Forecast | 2.93 |
| 3rd UP Forecast | 2.87 |
| 2nd UP Forecast | 2.83 |
| 1st UP Forecast | 2.79 |
| 1st DOWN Forecast | 2.69 |
| 2nd DOWN Forecast | 2.65 |
| 3rd DOWN Forecast | 2.61 |
| 4th DOWN Forecast | 2.55 |
SNGX Forecast2025
| 4th UP Forecast | 30.74 |
| 3rd UP Forecast | 21.76 |
| 2nd UP Forecast | 16.21 |
| 1st UP Forecast | 10.66 |
| 1st DOWN Forecast | -5.18 |
| 2nd DOWN Forecast | -10.73 |
| 3rd DOWN Forecast | -16.28 |
| 4th DOWN Forecast | -25.26 |
Soligenix Inc ( NASDAQ USA Symbol : SNGX )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
SNGX Business Profile
Soligenix, Inc., a late-stage biopharmaceutical company, focuses on developing and commercializing products to treat rare diseases in the United States. It operates in two segments, Specialized BioTherapeutics and Public Health Solutions. The Specialized BioTherapeutics segment develops SGX301, a novel photodynamic therapy, which has completed Phase III clinical trial to treat cutaneous T-cell lymphoma; and SGX942, an innate defense regulator technology that is in Phase III clinical trial to treat oral mucositis in head and neck cancer. This segment also offers proprietary formulations of oral beclomethasone 17,21-dipropionate, which has completed Phase I/II clinical trial for the prevention/treatment of gastrointestinal disorders characterized by severe inflammation, including SGX203 for pediatric Crohn's disease and SGX201 for acute radiation enteritis. The Public Health Solutions segment is involved in the development of RiVax, a ricin toxin vaccine candidate, which has completed Phase Ia and Ib clinical trials; SGX943, a melioidosis therapeutic candidate that is in pre-clinical stage for the treatment of antibiotic resistant and emerging infectious diseases; ThermoVax, a technology in pre-clinical development for thermostabilizing vaccines; and CiVax, a vaccine candidate in pre-clinical development for the prevention of COVID-19. The company was formerly known as DOR BioPharma, Inc. and changed its name to Soligenix, Inc. in 2009. Soligenix, Inc. was incorporated in 1987 and is headquartered in Princeton, New Jersey. Address: 29 Emmons Drive, Princeton, NJ, United States, 08540
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service